390 Matrix Metalloproteinases Substrate 13

<strong>390 Matrix Metalloproteinases Substrate 13</strong>_x000D_ <strong>Catalog number:</strong> B2011277_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1675.9 g/mol_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong>_x000D_ 390 MMP Substrate 13, NFF-3, Matrix Metalloproteinases_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Khalil HH, Osman HA, Teleb M, Darwish AI, Abu-Serie MM, Khattab SN, Haiba NS. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma ChemMedChem. 2021 Dec 14;16(24):3701-3719._x000D_ 2: Hardy E, Fernandez-Patron C. Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis Biomolecules. 2021 Mar 6;11(3):390._x000D_ 3: Gabriel CER, Nguyen TT, Gargano EM, Fisher JF, Chang M, Mobashery S. Metabolism of the Selective Matrix Metalloproteinase-9 Inhibitor (R)-ND-336 ACS Pharmacol Transl Sci. 2021 Apr 6;4(3):1204-1213._x000D_ 4: Li J, Wang JM, Liu YH, Zhang Z, Han N, Wang JY, Xue SH, Wang P. [Effect of microRNA-106b on the invasion and proliferation of trophoblasts through targeting MMP-2] Zhonghua Fu Chan Ke Za Zhi. 2017 May 25;52(5):327-332._x000D_ 5: Yadav MR, Murumkar PR, Zambre VP. Advances in studies on collagenase inhibitors Exp Suppl. 2012;103:83-135._x000D_ 6: Ieguchi K, Tomita T, Takao T, Omori T, Mishima T, Shimizu I, Tognolini M, Lodola A, Tsunoda T, Kobayashi S, Wada S, Maru Y. Analysis of ADAM12-Mediated Ephrin-A1 Cleavage and Its Biological Functions Int J Mol Sci. 2021 Mar 1;22(5):2480._x000D_ 7: Watanabe N, Ikeda U. Matrix metalloproteinases and atherosclerosis Curr Atheroscler Rep. 2004 Mar;6(2):112-20._x000D_ 8: Krengel S, Alexander M, Brinckmann J, Tronnier M. MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UVB-light J Cutan Pathol. 2002 Aug;29(7):390-6._x000D_ 9: Kiiski H, Långsjö J, Tenhunen J, Ala-Peijari M, Huhtala H, Hämäläinen M, Moilanen E, Peltola J. S100B, NSE and MMP-9 fail to predict neurologic outcome while elevated S100B associates with milder initial clinical presentation after aneurysmal subarachnoid hemorrhage J Neurol Sci. 2018 Jul 15;390:129-134._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/26170062">10: Shiba N, Miyazaki D, Yoshizawa T, Fukushima K, Shiba Y, Inaba Y, Imamura M, Takeda S, Koike K, Nakamura A. Differential roles of MMP-9 in early and late stages of dystrophic muscles in a mouse model of Duchenne muscular dystrophy Biochim Biophys Acta. 2015 Oct;1852(10 Pt A):2170-82. </a>_x000D_ _x000D_ <strong>Products Related to 390 Matrix Metalloproteinases Substrate 13 can be found at</strong> <a href="https://moleculardepot.com/product-category/Substrates/"> Substrates</a>